Patent ID: 9061352
Filing Date: 2015-06-23
Classification: A61K,A61M,A61P,B22F,C22C

Abstract:
1. A respirable dry powder comprising respirable dry particles comprising magnesium lactate in an amount that provides magnesium ion in an amount of at least about 5%, leucine in an amount of about 5% to about 45%, and one or more therapeutic agents in an amount of about 0.01% to about 20%, wherein all percentages are weight percentages and the magnesium lactate, leucine and one or more therapeutic agents amount to 100 weight %, wherein the respirable dry particles have a volume median geometric diameter (VMGD) at 1 bar as measured using a HELOS/RODOS system of about 5 microns or less, a dispersibility ratio (1/4 bar) of 1.5 or less, and a tap density of greater than about 0.4 g/cc.